<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Public Health">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Public Health</JournalTitle>
      <Issn>2251-6085</Issn>
      <Volume>53</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>02</Month>
        <Day>28</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">MitoQ Alleviated PM2.5 Induced Pulmonary Epithelial Cells  Injury by Inhibiting Mitochondrial-Mediated Apoptosis</title>
    <FirstPage>614</FirstPage>
    <LastPage>624</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Ai-Bin</FirstName>
        <LastName>Weng</LastName>
        <affiliation locale="en_US">Department of Pharmacy, The Affiliated Hospital of Putian University, Fujian Province, China</affiliation>
      </Author>
      <Author>
        <FirstName>Meng-Meng</FirstName>
        <LastName>Deng</LastName>
        <affiliation locale="en_US">Pharmaceutical and Medical Technology College, Putian University, Fujian Province, China</affiliation>
      </Author>
      <Author>
        <FirstName>Xiao-Dan</FirstName>
        <LastName>Liu</LastName>
        <affiliation locale="en_US">Pharmaceutical and Medical Technology College, Putian University, Fujian Province, China</affiliation>
      </Author>
      <Author>
        <FirstName>Hai-Bin</FirstName>
        <LastName>Wang</LastName>
        <affiliation locale="en_US">Pharmaceutical and Medical Technology College, Putian University, Fujian Province, China</affiliation>
      </Author>
      <Author>
        <FirstName>Qi</FirstName>
        <LastName>Lin</LastName>
        <affiliation locale="en_US">Key Laboratory for Translational Oncology of Fujian Province, Putian University, Fujian Province, China</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>04</Month>
        <Day>18</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>09</Month>
        <Day>18</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Fine particulate matter (PM2.5), an important component of ambient air pollution, induces significant adverse health effects. MitoQuinone (MitoQ), a mitochondria-targeted antioxidant, has been reported to play a protective role in various diseases. However, the roles of MitoQ in PM2.5 induced pulmonary toxicity remains to be elucidated.
&#xD;

Methods: All the experiments were performed at Higher Educational Key Laboratory for Translational Oncology of Fujian Province, Putian City, China in 2023. Pulmonary epithelial cells (A549) were pretreated with 4 &#xB5;M MitoQ for 2 h and exposed to PM2.5 for 24 h. Cell viability was tested through CCK8 assay. Oxidative stress state and active mitochondria was used to study MitoQ&#x2019;s effect on PM2.5 induced injury, and cell apoptosis was measured using a flow cytometer and analyzed by Bcl-2 family.
&#xD;

Results: MitoQ pretreatment significantly relieved a decreased cell viability, subsequently, MitoQ alleviated ROS production and prevented the reduction of T-AOC and GSH and increased the expression of NF-E2-related factor 2 (Nrf2) and p62 in A549 cells exposed to PM2.5. MitoQ restored the decreased mitochondrial dysfunction and dynamics disorder and inhibited activated mitochondrial-mediated apoptosis induced by PM2.5. Furthermore, the decreased ratio of Bcl-2/Bax and expression of Mcl-1 and the enhanced expression of Caspase-3 were reversed by MitoQ pretreatment.
&#xD;

Conclusion: MitoQ might be regarded as a potential drug to relieve PM2.5 induced pulmonary epithelial cells damage.</abstract>
    <web_url>https://ijph.tums.ac.ir/index.php/ijph/article/view/31789</web_url>
    <pdf_url>https://ijph.tums.ac.ir/index.php/ijph/article/download/31789/8188</pdf_url>
  </Article>
</Articles>
